129 related articles for article (PubMed ID: 15450100)
1. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
[TBL] [Abstract][Full Text] [Related]
2. Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence.
Célérier E; Ahdepil T; Wikander H; Berrendero F; Nyberg F; Maldonado R
Neuropharmacology; 2006 Jun; 50(7):788-806. PubMed ID: 16443242
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of nicotine-induced rewarding effects in A2A knockout mice.
Castañé A; Soria G; Ledent C; Maldonado R; Valverde O
Neuropharmacology; 2006 Sep; 51(3):631-40. PubMed ID: 16793068
[TBL] [Abstract][Full Text] [Related]
4. The lack of A2A adenosine receptors diminishes the reinforcing efficacy of cocaine.
Soria G; Castañé A; Ledent C; Parmentier M; Maldonado R; Valverde O
Neuropsychopharmacology; 2006 May; 31(5):978-87. PubMed ID: 16123743
[TBL] [Abstract][Full Text] [Related]
5. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
[TBL] [Abstract][Full Text] [Related]
6. Improved spatial recognition memory in mice lacking adenosine A2A receptors.
Wang JH; Ma YY; van den Buuse M
Exp Neurol; 2006 Jun; 199(2):438-45. PubMed ID: 16519887
[TBL] [Abstract][Full Text] [Related]
7. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro.
Whalley BJ; Wilkinson JD; Williamson EM; Constanti A
Neurosci Lett; 2004 Jul; 365(1):58-63. PubMed ID: 15234473
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
9. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
[TBL] [Abstract][Full Text] [Related]
10. Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1/A2a double knockout mice.
Berrendero F; Castañé A; Ledent C; Parmentier M; Maldonado R; Valverde O
Eur J Neurosci; 2003 Jan; 17(2):315-24. PubMed ID: 12542668
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice.
Castañé A; Robledo P; Matifas A; Kieffer BL; Maldonado R
Eur J Neurosci; 2003 Jan; 17(1):155-9. PubMed ID: 12534979
[TBL] [Abstract][Full Text] [Related]
12. The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA.
Ruiz-Medina J; Ledent C; Carretón O; Valverde O
J Psychopharmacol; 2011 Apr; 25(4):550-64. PubMed ID: 21262860
[TBL] [Abstract][Full Text] [Related]
13. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.
Valjent E; Mitchell JM; Besson MJ; Caboche J; Maldonado R
Br J Pharmacol; 2002 Jan; 135(2):564-78. PubMed ID: 11815392
[TBL] [Abstract][Full Text] [Related]
14. Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice.
Short JL; Ledent C; Borrelli E; Drago J; Lawrence AJ
Neuroscience; 2006 May; 139(2):661-70. PubMed ID: 16476524
[TBL] [Abstract][Full Text] [Related]
15. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
[TBL] [Abstract][Full Text] [Related]
16. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.
Touriño C; Ledent C; Maldonado R; Valverde O
Biol Psychiatry; 2008 Jun; 63(11):1030-8. PubMed ID: 17950256
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol.
Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE
J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275
[TBL] [Abstract][Full Text] [Related]
18. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol.
Borgkvist A; Marcellino D; Fuxe K; Greengard P; Fisone G
Neuropharmacology; 2008 Jan; 54(1):31-5. PubMed ID: 17686497
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic system does not play a major role in the precipitated cannabinoid withdrawal syndrome.
Sañudo-Peña MC; Force M; Tsou K; McLemore G; Roberts L; Walker JM
Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1121-4. PubMed ID: 11216447
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.
Chan ES; Fernandez P; Merchant AA; Montesinos MC; Trzaska S; Desai A; Tung CF; Khoa DN; Pillinger MH; Reiss AB; Tomic-Canic M; Chen JF; Schwarzschild MA; Cronstein BN
Arthritis Rheum; 2006 Aug; 54(8):2632-42. PubMed ID: 16871530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
